AT1 0.00% 2.0¢ atomo diagnostics limited

Ann: Atomo and Access Bio renegotiate supply agreements, page-15

  1. 612 Posts.
    lightbulb Created with Sketch. 534
    So we are now back to RAT's for revenue and another partner gone. Cannot see why they cannot right now line up forward sales subject to approval by TGA for the self test RAT. 20m RATS is not allot and I expect the government to subsidise these tests particularly for children and school's and government.
    The PCR test is $130-150/a pop so the demand for RAT's (retail $20 and wholsale $15) for public and private enterprise is billions of units.
    Very interesting to see what they deem is material with regard to one off fee (material would be $2-3m). Why, if it is material is the fee not disclosed?They talk about being a high growth company but the numbers a pithy.
    Last edited by zilliqua: 05/10/21
 
watchlist Created with Sketch. Add AT1 (ASX) to my watchlist
(20min delay)
Last
2.0¢
Change
0.000(0.00%)
Mkt cap ! $12.78M
Open High Low Value Volume
2.0¢ 2.0¢ 2.0¢ $5.672K 283.5K

Buyers (Bids)

No. Vol. Price($)
8 643375 2.0¢
 

Sellers (Offers)

Price($) Vol. No.
2.1¢ 152000 2
View Market Depth
Last trade - 15.46pm 11/09/2024 (20 minute delay) ?
AT1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.